Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation
- PMID: 18922992
- PMCID: PMC2572285
- DOI: 10.2215/CJN.01310308
Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation
Abstract
Background and objectives: In the first months after successful kidney transplantation, hypophosphatemia and renal phosphorus wasting are common and related to inappropriately high parathyroid hormone (PTH) and fibroblast growth factor-23 (FGF-23) levels. Little is known about the long-term natural history of renal phosphorus homeostasis in renal transplant recipients.
Design, setting, participants: We prospectively followed parameters of mineral metabolism (including full-length PTH and FGF-23) in 50 renal transplant recipients at the time of transplantation (Tx), at month 3 (M3) and at month 12 (M12). Transplant recipients were (1:1) matched for estimated GFR with chronic kidney disease (CKD) patients.
Results: FGF-23 levels (Tx: 2816 [641 to 10665] versus M3: 73 [43 to 111] versus M12: 56 [34 to 78] ng/L, median [interquartile range]) and fractional phosphorus excretion (FE(phos); M3: 45 +/- 19% versus M12: 37 +/- 13%) significantly declined over time after renal transplantation. Levels 1 yr after transplantation were similar to those in CKD patients (FGF-23: 47 [34 to 77] ng/L; FE(phos) 35 +/- 16%). Calcium (9.1 +/- 0.5 versus 8.9 +/- 0.3 mg/dl) and PTH (27.2 [17.0 to 46.0] versus 17.5 [11.7 to 24.4] ng/L) levels were significantly higher, whereas phosphorus (3.0 +/- 0.6 versus 3.3 +/- 0.6 mg/dl) levels were significantly lower 1 yr after renal transplantation as compared with CKD patients.
Conclusions: Data indicate that hyperphosphatoninism and renal phosphorus wasting regress by 1 yr after successful renal transplantation.
Similar articles
-
Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?Kidney Int. 2006 Oct;70(8):1486-94. doi: 10.1038/sj.ki.5001788. Epub 2006 Aug 30. Kidney Int. 2006. PMID: 16941023
-
Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients.Am J Transplant. 2007 May;7(5):1193-200. doi: 10.1111/j.1600-6143.2007.01753.x. Epub 2007 Mar 12. Am J Transplant. 2007. PMID: 17359508 Clinical Trial.
-
Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.Transplant Proc. 2012 Nov;44(9):2551-4. doi: 10.1016/j.transproceed.2012.09.070. Transplant Proc. 2012. PMID: 23146451
-
[Disturbance of phosphorus metabolism in chronic kidney disease].Clin Calcium. 2009 Feb;19(2):166-72. Clin Calcium. 2009. PMID: 19182354 Review. Japanese.
-
Post-renal transplantation hypophosphatemia: a review and novel insights.Curr Opin Nephrol Hypertens. 2006 Mar;15(2):97-104. doi: 10.1097/01.mnh.0000203187.49890.cc. Curr Opin Nephrol Hypertens. 2006. PMID: 16481873 Review.
Cited by
-
Markers of bone remodeling are associated with arterial stiffness in renal transplanted subjects.J Nephrol. 2015 Dec;28(6):765-72. doi: 10.1007/s40620-015-0201-5. Epub 2015 Apr 29. J Nephrol. 2015. PMID: 25920618
-
FGF23 is associated with early post-transplant hypophosphataemia and normalizes faster than iPTH in living donor renal transplant recipients: a longitudinal follow-up study.Clin Kidney J. 2016 Oct;9(5):669-76. doi: 10.1093/ckj/sfw065. Epub 2016 Jul 27. Clin Kidney J. 2016. PMID: 27679713 Free PMC article.
-
Bone disease after renal transplantation.Nat Rev Nephrol. 2010 Jan;6(1):32-40. doi: 10.1038/nrneph.2009.192. Epub 2009 Nov 17. Nat Rev Nephrol. 2010. PMID: 19918255 Free PMC article. Review.
-
Electrolyte and Acid-Base Disorders in the Renal Transplant Recipient.Front Med (Lausanne). 2018 Oct 2;5:261. doi: 10.3389/fmed.2018.00261. eCollection 2018. Front Med (Lausanne). 2018. PMID: 30333977 Free PMC article. Review.
-
Efficacy of iguratimod on mineral and bone disorders after kidney transplantation: a preliminary study.Ren Fail. 2023;45(2):2256418. doi: 10.1080/0886022X.2023.2256418. Epub 2023 Oct 31. Ren Fail. 2023. PMID: 37905940 Free PMC article.
References
-
- Levi M: Post-transplant hypophosphatemia. Kidney Int 59: 2377–2387, 2001 - PubMed
-
- Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y: Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 19: 1281–1287, 2004 - PubMed
-
- Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett S-A, Juppner H, Wolf M: Post-transplant hypophosphatemia: Tertiary ′hyper-phosphatoninism’? Kidney Int 70: 1486–1494, 2006 - PubMed
-
- Evenepoel P, Naesens M, Claes K, Kuypers D, Vanrenterghem Y: Tertiary ′hyperphosphatoninism’ accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant 7: 1193–1200, 2007 - PubMed
-
- Ghanekar H, Welch BJ, Moe OW, Sakhaee K: Post-renal transplantation hypophosphatemia: A review and novel insights. Curr Opin Nephrol Hypertens 15: 97–104, 2006 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous